Physician

Arwa Alsamarae, M.D.

According to 2025 Medicare claims, Arwa Alsamarae, M.D. (NPI: 1487072534) practices ophthalmology in the Santa Rosa-Petaluma, CA market, with the plurality of this provider's patient population coming from Sonoma, CA. This provider's primary affiliated billing organization is EYE CARE INSTITUTE, A MEDICAL CORPORATION (NPI: 1295740991; TIN: 942172516) and primary practice location at 95403-2122.

Alsamarae's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,093 traditional Medicare patients, billed 4,551 HCPCS/CPT codes, and received $444,736 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,018 prescription claims across 749 beneficiaries totaling $431,856 in drug costs, led by Rocklatan (Netarsudil Mesylat/Latanoprost). DME data shows 51 claims. Open Payments data shows 7 records totaling $142. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $7,384 to $444,736. Similarly, Part D prescription costs have moved sharply higher in recent years, from $8,367 to $431,856. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	62	91	$7,384
2019	368	733	$58,415
2020	957	2,954	$290,987
2021	945	3,430	$391,654
2022	1,020	3,780	$366,792
2023	1,051	4,221	$423,093
2024	1,093	4,551	$444,736

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	80	160	$8,367
2016	76	210	$16,139
2017	155	689	$45,109
2018	233	903	$64,106
2019	224	737	$57,856
2020	338	973	$118,020
2021	498	1,755	$262,259
2022	623	2,411	$472,887
2023	659	2,535	$473,475
2024	749	3,018	$431,856

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	48	48	$2,964
2021	68	69	$4,613
2022	52	52	$3,036
2023	82	82	$5,863
2024	51	51	$3,678

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	320	415	$102
92014	Established patient complete exam of visual system	611	650	$99
92012	Established patient problem focused exam of visual system	555	838	$72
92083	Exam of visual field with extended testing	542	737	$54
92133	Imaging of optic nerve	418	446	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rocklatan	Netarsudil Mesylat/Latanoprost	133	7,184	$86,621
Rhopressa	Netarsudil Mesylate	127	7,329	$75,782
Restasis	Cyclosporine	40	2,790	$55,352
Lumigan	Bimatoprost	68	4,222	$37,068
Cyclosporine	Cyclosporine	33	1,845	$18,114

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2203	Spherocylinder, bifocal, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	17	17	$1,558
V2020	Frames, purchases	N	23	23	$1,535
V2103	Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens	N	11	11	$584

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	7	$142	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Arwa Alsamarae, M.D.?

Tedicare shows public-source Medicare data for Arwa Alsamarae, M.D. (NPI 1487072534), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Arwa Alsamarae, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Arwa Alsamarae, M.D.?

Arwa Alsamarae, M.D. is linked to EYE CARE INSTITUTE, A MEDICAL CORPORATION (billing NPI 1295740991) in the available physician profile data.

Does Arwa Alsamarae, M.D. have Open Payments data?

Arwa Alsamarae, M.D. has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.